Compare XMTR & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XMTR | STVN |
|---|---|---|
| Founded | 2013 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Containers/Packaging |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.7B |
| IPO Year | 2021 | 2021 |
| Metric | XMTR | STVN |
|---|---|---|
| Price | $94.31 | $17.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $58.60 | $25.67 |
| AVG Volume (30 Days) | ★ 774.4K | 364.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | ★ 26.95 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $686,631,000.00 | N/A |
| Revenue This Year | $23.76 | $9.67 |
| Revenue Next Year | $18.38 | $9.99 |
| P/E Ratio | ★ N/A | $27.15 |
| Revenue Growth | ★ 25.87 | N/A |
| 52 Week Low | $30.63 | $12.89 |
| 52 Week High | $99.86 | $28.00 |
| Indicator | XMTR | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 66.64 | 50.76 |
| Support Level | $56.76 | $16.75 |
| Resistance Level | $99.86 | $19.41 |
| Average True Range (ATR) | 4.44 | 0.96 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 96.41 | 51.78 |
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.